Is DMII stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Drugs Made In America Acquisition II Corp. Ordinary Shares has a Smart Value Score of 30/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

DMII

Drugs Made In America Acquisition II Corp. Ordinary Shares

NASDAQ: DMII · FINANCIAL SERVICES · SHELL COMPANIES

$10.02

+0.10% today

Updated 2026-04-30

Market cap

$637.64M

P/E ratio

66.73

P/S ratio

—

EPS (TTM)

$0.15

Dividend yield

—

52W range

$10 – $10

Volume

0.1M

Market cap

$637.64M

P/E ratio

66.73

P/S ratio

—

EPS (TTM)

$0.15

Dividend yield

—

52W range

$10 – $10

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.5

Profitability

4.0

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-314864.00

- P/E 66.73x — expensive valuation

Key financials

Revenue Net Income Free Cash Flow

Metric	2024	2025	TTM
Revenue	—	$0.00	—
Net income	$-151719.00	$4.19M	$4.33M
EPS	—	—	$0.15
Free cash flow	$-194299.00	$-1.02M	$-314864.00
Profit margin	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
DMII	$637.64M	30	4.3	3.5	4.0	5.0	—	Avoid
BRK-A	$1.01T	53	3.3	7.5	5.0	8.0	—	Buy
BRK-B	$1.01T	54	3.3	7.5	5.0	8.0	—	Buy
JPM	$844.23B	73	8.0	8.0	5.7	5.5	—	Strong Buy
V	$596.57B	68	7.3	10.0	5.0	5.5	—	Strong Buy
MA	$449.94B	70	8.0	10.0	4.3	6.0	—	Strong Buy

Smart narrative

Drugs Made In America Acquisition II Corp. Ordinary Shares trades at $10.02. representing a P/E of 66.73x trailing earnings. Our Smart Value Score of 30/100 indicates the stock is weak.

Frequently asked questions

What is Drugs Made In America Acquisition II Corp. Ordinary Shares's stock price?

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) trades at $10.02.

Is Drugs Made In America Acquisition II Corp. Ordinary Shares overvalued?

Smart Value Score 30/100 (Grade F, Strong Sell).

What is the price target of Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)?

The analyst target price is $—, representing NaN% downside from the current price of $10.02.

Company info

SectorFINANCIAL SERVICES

IndustrySHELL COMPANIES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE—

Beta—

50D MA$9.98

200D MA$9.95

Shares out0.06B

Float0.05B

Short ratio—

Avg volume0.1M

Performance

1 week+0.00%

1 month+0.40%

3 months+0.50%

YTD+1.11%

1 year—

3 years—

5 years—

Compare

DMII vs BRK-A →DMII vs BRK-B →DMII vs JPM →Stock screener →